학술논문

RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE (TM)-FF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRE-CANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX
Document Type
Journal
Source
GASTROENTEROLOGY; MAY 2020, 158 6, pS136-pS136, 1p. Supplement: 1
Subject
Language
English
ISSN
15280012